您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2010, Vol. 48 ›› Issue (3): 113-.

• 论文 • 上一篇    下一篇

斯普林注射液在中晚期肺癌综合治疗中的作用

陈燕平,刘云聪,吴海霞   

  1. 贵州省人民医院肿瘤科, 贵阳 550002
  • 收稿日期:2010-01-20 出版日期:2010-03-16 发布日期:2010-03-16
  • 作者简介:陈燕平(1970- ),女,副主任医师,主要从事恶性肿瘤综合治疗研究。 Email: zenghao1234hui@sina.com

Role of sipulin injection in comprehensive treatment of lung cancer in medium and terminal stages

CHEN Yan-ping, LIU Yun-cong, WU Hai-xia   

  1. Department of Oncology, Guizhou Provincial People′s Hospital, Guiyang 550002, China
  • Received:2010-01-20 Online:2010-03-16 Published:2010-03-16

摘要:

目的  观察斯普林注射液配合放、化疗治疗中晚期肺癌的疗效。方法  将147例中晚期肺癌患者随机分为斯普林注射液配合放、化疗组(治疗组,75例),单纯放、化疗组(对照组,72例),两组放、化疗方法相同,治疗组在放、化疗开始即给予斯普林10mL,加入0.9%氯化钠注射液250mL中静滴,连用14d,21d为1周期,共4~6周期,对多个临床指标进行比较观察。结果  治疗组近期疗效为60.0%,对照组为48.6%,两组无统计学差异(P>0.05)。治疗组1、2年生存率分别为58.9%、41.1%,对照组分别为42.3%、25.4%,两组有统计学差异(P<0.05)。治疗组患者的生活质量、治疗后T细胞亚群及NK细胞活性明显高于对照组,血液学各项指标下降程度、消化道不良反应及放射性食管炎均明显轻于对照组,两组有统计学差异(P<0.05)。结论  斯普林注射液用于配合放、化疗治疗中晚期肺癌有一定疗效。

关键词: 中晚期肺癌;化学治疗;放射治疗;斯普林

Abstract:

Objective   To observe the clinical effects of sipulin combined with radiotherapy and chemotherapy. Methods  147 patients were randomly divided into 2 groups: the sipulin group was treated with sipulin combined with radiotherapy and chemotherapy(n=75) and the control group was only treated with radiotherapy and chemotherapy(n=72). The methods of radiotherapy and chemotherapy were identical in the two groups. The sipulin group received intravenous infusions of sipulin(10mL in 250mL 0.9% NS) for 14 days, 4-6 cycles (21days in one cycle). The clinical indexes were observed and analyzed. Results   The efficiency rate was 60.0% in the sipulin group and 48.6% in the control group, and there was no significant difference between the two groups(P>0.05). The 1-and 2-year survival rates in the sipulin group (58.9% and 41.1%)were significantly higher than those in the control group (42.3% and 25.4%) (P<0.05). The quality of life  and the counts of T and NK cells after treatment in the sipulin group were significantly increased. The decline of the hematocyte count, the side effect of the alimentary tract and radioesophagitis were  evidently reduced in the sipulin group compared with the control group. Conclusion  Sipulin injection is effective and safe as an adjuvant in radiotherapy and chemotherapy for lung cancer in medium and terminal stages.

Key words: Lung cancer in medium and terminal stages; Chemotherapy; Radiotherapy; Sipulin injection

中图分类号: 

  • R734.2
[1] 徐晓娅,毕玉莉,姜曼,许继映,张鹏飞,韩明勇. 血管内皮生长因子促进肺转移相关受体通路的研究[J]. 山东大学学报(医学版), 2013, 51(11): 25-29.
[2] 张鹏飞,隋萍,张颖,戴建建,林琦,韩明勇. 妊娠合并肝内胆管细胞癌多发转移1例[J]. 山东大学学报(医学版), 2013, 51(11): 108-110.
[3] 田甜甜1,李际盛1,王亚伟1,马道新2,王秀问1. 染料木黄酮在小细胞肺癌H446细胞中通过抑制FoxM1通路发挥抗肿瘤作用[J]. 山东大学学报(医学版), 2013, 51(06): 44-48.
[4] 刘冰1,于壮1,侯宪鹏1,姚如永2. EGFR和HER-3在人肺腺癌细胞及培美曲塞二钠耐药细胞中的表达差异[J]. 山东大学学报(医学版), 2013, 51(5): 20-23.
[5] 阿力木江·赛提瓦尔地,张涛,帕提古丽·阿尔西丁,刘莉. 重组人血管内皮抑素联合吉西他滨及顺铂治疗晚期非小细胞肺癌的临床分析[J]. 山东大学学报(医学版), 2013, 51(3): 95-98.
[6] 董雪丽,牟晓燕,刘庆亮,孙杰. 塞来昔布联合厄罗替尼对人肺癌裸鼠移植瘤生长及血管生成的影响[J]. 山东大学学报(医学版), 2013, 51(2): 49-52.
[7] 韩觉明,林琦,戴建建,张颖,韩明勇. 全内脏转位合并右肺癌1例[J]. 山东大学学报(医学版), 2012, 50(10): 130-131.
[8] 刘庆亮1,牟晓燕1,王静2,迟翔宇2,张敏3,马卫霞3. RNA干扰及厄洛替尼阻断EGFR信号途径对A549细胞抗增殖的影响[J]. 山东大学学报(医学版), 2012, 50(9): 11-.
[9] 范恒建,张玉可,肖伟,张一,李海军,王得翔 . 肺腺癌患者外周血Treg和Th17细胞的变化及其对预后的影响[J]. 山东大学学报(医学版), 2012, 50(9): 73-78.
[10] 王吉霞,李贵新,黄琰,王丽娟. 非小细胞肺癌组织中E1AF、MMP-7、uPA的表达及其临床意义[J]. 山东大学学报(医学版), 2012, 50(7): 109-.
[11] 徐统震,孙雪飞,任冬梅,杨国涛. 木犀草素抑制肺癌细胞A549的增殖及其联合化疗作用[J]. 山东大学学报(医学版), 2012, 50(7): 50-54.
[12] 刘海荣1,于金明2,李岩1,梁婧1,刘晓琳1. ER、PR、C-erB-2与肺腺癌骨转移的相关性研究[J]. 山东大学学报(医学版), 2012, 50(4): 91-.
[13] 马育华1,2, 郑燕3,郏雁飞3,汪运山3. EGFR与DEC1蛋白共表达促进肺腺癌肿瘤细胞淋巴结转移[J]. 山东大学学报(医学版), 2012, 50(3): 24-28.
[14] 孙雪飞,裴艳涛,尹秋伟,杨国涛,王德江. 藤梨根提取物对肺癌A549细胞裸鼠移植瘤的抑制作用[J]. 山东大学学报(医学版), 2012, 50(2): 38-42.
[15] 李鹏,刘奇,韩明勇. PET-CT、血清CEA及CYFRA21-1预测靶向药物对非小细胞肺癌疗效的研究[J]. 山东大学学报(医学版), 2012, 50(1): 129-132.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!